Human papillomavirus infection and cervical intraepithelial neoplasia progression are associated with increased vaginal microbiome diversity in a Chinese cohort/Experiment 4

From BugSigDB


Reviewed Marked as Reviewed by Atrayees on 2023-6-28

Curated date: 2021/03/20

Curator: Cynthia Anderson

Revision editor(s): Cynthia Anderson, WikiWorks

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Posterior fornix of vagina Pars posterior fornicis vaginae,Posterior fornix,Posterior part of fornix of vagina,Posterior fornix of vagina,posterior fornix of vagina
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Cervical cancer cancer of uterine cervix,cervical neoplasm,cervix cancer,cervix uteri cancer,malignant cervical neoplasm,malignant cervical tumor,malignant cervix neoplasm,malignant cervix tumor,malignant cervix uteri neoplasm,malignant cervix uteri tumor,malignant neoplasm of cervix,malignant neoplasm of cervix uteri,malignant neoplasm of the cervix,malignant neoplasm of the cervix uteri,malignant neoplasm of the uterine cervix,malignant neoplasm of uterine cervix,malignant tumor of cervix,malignant tumor of cervix uteri,malignant tumor of the cervix,malignant tumor of the cervix uteri,malignant tumor of the uterine cervix,malignant tumor of uterine cervix,malignant uterine cervix neoplasm,malignant uterine cervix tumor,tumor of the cervix uteri,uterine cervical neoplasm,uterine cervix cancer,Cervical cancer,cervical cancer
Group 0 name Corresponds to the control (unexposed) group for case-control studies
healthy control
Group 1 name Corresponds to the case (exposed) group for case-control studies
cervical cancer
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
women with cervical cancer confirmed by biopsy
Group 0 sample size Number of subjects in the control (unexposed) group
68
Group 1 sample size Number of subjects in the case (exposed) group
9
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
14 days

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3-V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Statistical test
LEfSe
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
4

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
increased
Chao1 Abundance-based estimator of species richness
increased

Signature 1

Reviewed Marked as Reviewed by Atrayees on 2023-6-28

Curated date: 2021/03/20

Curator: Cynthia Anderson

Revision editor(s): Cynthia Anderson

Source: Figure 5

Description: The unique taxa and microbiomarkers for different groups

Abundance in Group 1: increased abundance in cervical cancer

NCBI Quality ControlLinks
Bacillales
Fusobacteriales
Fusobacteriia
Fusobacteriota
Bacillaceae
Pseudomonadota
Bacillus
Bacteroidia
Bacteroidales
Bacteroidota
Betaproteobacteria
Sneathia
Leptotrichiaceae
Comamonadaceae
Burkholderiales
Acidovorax
Fusobacterium
Fusobacteriaceae
Oceanobacillus
Oceanobacillus profundus
Porphyromonadaceae
Porphyromonas
Veillonellaceae
Negativicutes
Selenomonadales
Eubacteriales
Anaerococcus
Porphyromonas uenonis

Revision editor(s): Cynthia Anderson